Indomethacin-induced	indomethacin-induced	O	O
renal	renal	O	B_disease
insufficiency	insufficiency	O	I_disease
:	:	O	O
recurrence	recurrence	O	O
on	on	O	O
rechallenge	rechallenge	O	O
.	.	O	O

We	we	O	O
have	have	O	O
reported	reported	O	O
a	a	O	O
case	case	O	O
of	of	O	O
acute	acute	O	O
oliguric	oliguric	O	O
renal	renal	O	B_disease
failure	failure	O	I_disease
with	with	O	O
hyperkalemia	hyperkalemia	O	S_disease
in	in	O	O
a	a	O	O
patient	patient	O	O
with	with	O	O
cirrhosis	cirrhosis	O	S_disease
,	,	O	O
ascites	ascites	O	S_disease
,	,	O	O
and	and	O	O
cor	cor	O	O
pulmonale	pulmonale	O	O
after	after	O	O
indomethacin	indomethacin	S_chemical	O
therapy	therapy	O	O
.	.	O	O

Prompt	prompt	O	O
restoration	restoration	O	O
of	of	O	O
renal	renal	O	O
function	function	O	O
followed	followed	O	O
drug	drug	O	O
withdrawal	withdrawal	O	O
,	,	O	O
while	while	O	O
re-exposure	re-exposure	O	O
to	to	O	O
a	a	O	O
single	single	O	O
dose	dose	O	O
of	of	O	O
indomethacin	indomethacin	S_chemical	O
caused	caused	O	O
recurrence	recurrence	O	O
of	of	O	O
acute	acute	O	O
reversible	reversible	O	O
oliguria	oliguria	O	O
.	.	O	O

Our	our	O	O
case	case	O	O
supports	supports	O	O
the	the	O	O
hypothesis	hypothesis	O	O
that	that	O	O
endogenous	endogenous	O	O
renal	renal	O	O
prostaglandins	prostaglandins	S_chemical	O
play	play	O	O
a	a	O	O
role	role	O	O
in	in	O	O
the	the	O	O
maintenance	maintenance	O	O
of	of	O	O
renal	renal	O	O
blood	blood	O	O
flow	flow	O	O
when	when	O	O
circulating	circulating	O	O
plasma	plasma	O	O
volume	volume	O	O
is	is	O	O
diminished	diminished	O	O
.	.	O	O

Since	since	O	O
nonsteroidal	nonsteroidal	O	O
anti-inflammatory	anti-inflammatory	O	O
agents	agents	O	O
interfere	interfere	O	O
with	with	O	O
this	this	O	O
compensatory	compensatory	O	O
mechanism	mechanism	O	O
and	and	O	O
may	may	O	O
cause	cause	O	O
acute	acute	O	B_disease
renal	renal	O	B_disease
failure	failure	O	I_disease
,	,	O	O
they	they	O	O
should	should	O	O
be	be	O	O
used	used	O	O
with	with	O	O
caution	caution	O	O
in	in	O	O
such	such	O	O
patients	patients	O	O
.	.	O	O

